- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 213/55 - Acids; Esters
Patent holdings for IPC class C07D 213/55
Total number of patents in this class: 284
10-year publication summary
23
|
21
|
26
|
20
|
18
|
18
|
22
|
19
|
23
|
5
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
H. Lundbeck A/S | 1252 |
11 |
The Scripps Research Institute | 1364 |
7 |
Sutro Biopharma, Inc. | 148 |
7 |
Chugai Seiyaku Kabushiki Kaisha | 1259 |
6 |
Bristol-myers Squibb Company | 5080 |
5 |
Saudi Arabian Oil Company | 11322 |
5 |
F. Hoffmann-La Roche AG | 7958 |
4 |
Sumitomo Chemical Company, Limited | 8808 |
4 |
Gilead Sciences, Inc. | 1879 |
4 |
Receptos LLC | 65 |
4 |
The Wistar Institute of Anatomy and Biology | 387 |
4 |
Janssen Pharmaceutica N.V. | 3839 |
3 |
Syngenta Crop Protection AG | 2790 |
3 |
Allergan, Inc. | 2600 |
3 |
FUJIFILM Corporation | 27102 |
3 |
The Board of Trustees of the University of Illinois | 2623 |
3 |
Takeda Pharmaceutical Company Limited | 2961 |
3 |
Abide Therapeutics, Inc. | 26 |
3 |
AC Immune S.A. | 234 |
3 |
Arizona Board of Regents, a Body Corporate of The State of Arizona Acting for and on Behalf of Arizona State University | 311 |
3 |
Other owners | 196 |